Pyoderma gangrenosum

E Maverakis, AV Marzano, ST Le, JP Callen… - Nature Reviews …, 2020 - nature.com
Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis that presents with rapidly
developing, painful skin ulcers hallmarked by undermined borders and peripheral erythema …

Pyoderma gangrenosum: treatment options

J Dissemond, AV Marzano, PJ Hampton… - Drugs, 2023 - Springer
Pyoderma gangrenosum is a rare neutrophilic dermatosis that leads to exceedingly painful
ulcerations of the skin. Although the exact pathogenesis is not yet fully understood, various …

ECCO guidelines on extraintestinal manifestations in inflammatory bowel disease

H Gordon, J Burisch, P Ellul, K Karmiris… - Journal of Crohn's …, 2024 - academic.oup.com
This is the second European Crohn's and Colitis Organisation [ECCO] evidence-based
consensus on extraintestinal manifestations [EIMs] of inflammatory bowel disease [IBD] and …

Practical aspects of the diagnosis and management of pyoderma gangrenosum

B Chen, W Li, B Qu - Frontiers in Medicine, 2023 - frontiersin.org
Pyoderma gangrenosum (PG) is a rare autoinflammatory ulcerative neutrophilic skin
disease. Its clinical presentation is a rapidly progressing painful skin ulcer with ill-defined …

Neutrophil extracellular traps and neutrophilic dermatosis: an update review

S Li, S Ying, Y Wang, Y Lv, J Qiao, H Fang - Cell Death Discovery, 2024 - nature.com
Neutrophils have both antimicrobial ability and pathogenic effect in the immune system,
neutrophil extracellular traps (NETs) formation is one of the representative behaviors of their …

Cutaneous manifestations of inflammatory bowel disease: basic characteristics, therapy, and potential pathophysiological associations

R He, S Zhao, M Cui, Y Chen, J Ma, J Li… - Frontiers in …, 2023 - frontiersin.org
Inflammatory bowel disease (IBD) is a chronic inflammatory disease typically involving the
gastrointestinal tract but not limited to it. IBD can be subdivided into Crohn's disease (CD) …

Pyoderma gangrenosum and interleukin inhibitors: a semi-systematic review

H Ben Abdallah, K Fogh, C Vestergaard, R Bech - Dermatology, 2022 - karger.com
Background: Pyoderma gangrenosum (PG) is a rare ulcerating skin disease associated with
multiple comorbidities and increased mortality. In recent decades, newer biologics such as …

Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: a semi‐systematic review

H Ben Abdallah, K Fogh, R Bech - International Wound Journal, 2019 - Wiley Online Library
Pyoderma gangrenosum (PG) is a rare ulcerative skin disease that presents a therapeutic
challenge. Tumour necrosis factor alpha (TNFα) inhibitors have been reported to …

Pyoderma gangrenosum in inflammatory bowel disease: a systematic review and meta-analysis

V States, S O'Brien, JP Rai, HL Roberts, M Paas… - Digestive diseases and …, 2020 - Springer
Background Pyoderma gangrenosum (PG) is an uncommon but severe extra-intestinal
manifestation (EIM) of inflammatory bowel disease (IBD). The incidence and risk factors for …

Inflammatory arthritis-associated pyoderma gangrenosum: a systematic review

E Sawka, A Zhou, E Latour, M Friedman… - Clinical …, 2021 - Springer
Abstract Introduction/Objectives Pyoderma gangrenosum (PG) is a rare, rapidly progressive
neutrophilic dermatosis commonly associated with systemic inflammatory diseases. We …